Leading the Path to a Cure Through Research
Leading the Path to a Cure Through Research Born and raised in Mitchell, South Dakota,…
News
The U.S. Food and Drug Administration Approves Brentuximab Vedotin (Adcetris) for Hodgkin Lymphoma
On November 11, 2022, the U.S. Food and Drug Administration (FDA) announced it has approved the use of brentuximab vedotin (Adcetris), for pediatric patients 2 years of age and older with previously untreated high-risk classical Hodgkin lymphoma (cHL).
Lymphoma Research Foundation Raises Over $1 Million at New York City Gala to Help Eradicate Lymphoma 
Lymphoma Research Foundation Raises Over $1 Million at New York City Gala to Help Eradicate…
Meet the 2022 Lymphoma Scientific Research Mentoring Program Scholars
The Lymphoma Scientific Research Mentoring Program (LSRMP) is a first-of-its-kind education and mentoring program for junior scientists who wish to focus on lymphoma clinical and laboratory/translational research.
Patient Perspectives: Advocating for Adolescents and Young Adults
On June 23rd and 24th, 2022, physicians and scientists from more than 40 academic and medical institutions, federal agencies, and pharmaceutical companies were brought together in Jersey City, New Jersey for the second Lymphoma Research Foundation’s (LRF) Adolescent and Young Adult (AYA) Lymphoma Consortium Scientific Workshop.
Trusting the Process and Celebrating Triumphs
Trusting the Process and Celebrating Triumphs Growing up in Cleveland, Ohio, Steven M. Horwitz, MD,…
Where Are They Now? Gita Thanaranjasingam, MD
When did you become interested in the study of medicine? In lymphoma? As a result…
Right Place at the Right Time
Right Place at the Right Time Sometimes, life has a strange way of preparing us…
Statement of Lymphoma Research Foundation on Access to Treatment
Policymakers in Washington, DC, and state capitols are considering measures to address the cost of health care, including prescription drugs, and to address insurance adequacy issues. As debate on these initiatives intensifies, we urge that policymakers consider the needs of people with lymphoma and lymphoma survivors.
Statement Of Lymphoma Research On Access To Quality Cancer Care In Response To Dobbs V. Jackson Women’s Health Organization
Statement of Lymphoma Research on Access to Quality Cancer Care In Response to Dobbs V.…
Stay informed with news, alerts and other resources.
